Thomas Kluz, Managing Partner at Niterra Ventures
Venture capital is making a comeback in healthcare, and this time, artificial intelligence (AI) is at the center of the movement.
According to Crunchbase, funding for AI-powered health-tech startups…
Continue Reading
Thomas Kluz, Managing Director at Niterra Ventures
What if the future of drug discovery no longer rests on bold experiments, but on disciplined partnerships where artificial intelligence becomes as indispensable to pharma as the laboratory…
Continue Reading
Thomas Kluz, Managing Director at Niterra Ventures
If the COVID-19 pandemic taught us anything, it is this: primary care physicians are the backbone of a functioning health system. Yet, in the United States, the supply of…
Continue Reading
Thomas Kluz, Managing Director at Niterra Ventures
“AI is going to replace doctors.”
It’s a provocative, yet increasingly common fear whispered in hospital corridors and debated in medical forums. For many clinicians, the idea that software could…
Continue Reading
Thomas Kluz, Managing Director at Niterra Ventures
The most consequential shift in modern medicine isn’t happening inside hospitals or biotech labs. It’s happening inside medical simulation labs / training centers.
Drug development has long been marked…
Continue Reading
Thomas Kluz, Managing Director at Niterra Ventures
As a veteran of multiple healthcare startups, it’s hard not to become immune to claims of technological developments which will “revolutionize patient care”.
To be fair, revolutionary changes do exist. Telehealth…
Continue Reading
Thomas Kluz, Managing Director at Niterra Venture
During the past ten years, I’ve collaborated and invested in several innovative healthcare organizations, and I have realized that AI has extended beyond just being a supporting tool for medical purposes. It…
Continue Reading
What You Should Know:
– Neoplas Med GmbH, a Greifswald-based medical technology company, has secured an $18M investment from Niterra Ventures Company to further develop and expand its innovative cold plasma wound care technology.
– The…
Continue Reading
Biosensor Platform Leverages Silicon Semiconductor Manufacturing for Scale
Technology Designed to Provide a Better View of Metabolic Health by Combining Glucose Information with Context Around Activities of Daily Living in One Device
$58 Million in Funding…
